Ruxolitinib therapy to Avoid Ventilation and improve outcome for deteriorating COVID-19 patiENts (RAVEN)
- Funded by LifeArc
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Funder
LifeArcPrincipal Investigator
Unspecified Unspecified UnspecifiedResearch Location
United KingdomLead Research Institution
King?s College London and Guy?s and St Thomas?Research Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Supportive care, processes of care and management
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Unspecified
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
The team will collaborate on the biomarker analysis with Dr Steven Chan's team at the University of Toronto, University Health Network who are also conducting a trial with ruxolitinib.